This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:pathogenesis:vitamind:low25d [09.16.2016] – [Anomalies] sallieq | home:pathogenesis:vitamind:low25d [10.27.2018] – [Anomalies] sallieq | ||
---|---|---|---|
Line 76: | Line 76: | ||
* **mortality in the Danish population** – A 2012 study of 247,574 subjects found that both lower and higher levels of 25-D were associated with an increased likelihood of mortality (right).(({{pubmed> | * **mortality in the Danish population** – A 2012 study of 247,574 subjects found that both lower and higher levels of 25-D were associated with an increased likelihood of mortality (right).(({{pubmed> | ||
- | * **U-shaped relationship between vitamin D levels | + | * **U-shaped relationship between vitamin D levels |
* **risk of breast cancer** – In a 2011 study of nurses who were predominantly premenopausal, | * **risk of breast cancer** – In a 2011 study of nurses who were predominantly premenopausal, | ||
* **risk of prostate cancer** – In a 2008 nested case-control study appearing in //Journal of the National Cancer Institute//, | * **risk of prostate cancer** – In a 2008 nested case-control study appearing in //Journal of the National Cancer Institute//, | ||
Line 86: | Line 86: | ||
* **atherosclerosis in African Americans** – Vitamin D is widely used to treat patients with osteoporosis and/or low vitamin D levels based on a medically accepted normal range. This " | * **atherosclerosis in African Americans** – Vitamin D is widely used to treat patients with osteoporosis and/or low vitamin D levels based on a medically accepted normal range. This " | ||
+ | |||
+ | {{tag> | ||
===== Notes and comments ===== | ===== Notes and comments ===== |